Clovis Upgraded At Credit Suisse Following Acquisition Rumor By: Benzinga via Benzinga September 21, 2016 at 07:38 AM EDT Clovis Oncology Inc (NASDAQ: CLVS) is a potential takeout target for a global pharma company, Credit Suisse’s Kennen MacKay ... Read More >> Related Stocks: Clovis Oncology Inc Eli Lilly Merck & Co